[1]
Masood Khan, M.T. 2022. Efficacy and Safety of Low Dose Thalidomide in Transfusion Dependent Thalassemia Patients: A Preliminary Study. International Journal of Pathology. 20, 1 (Apr. 2022), 2–6.